page 55 PTBICF > TREATMENT CENTERS, SPECIALISTS and CLINICS > HORMONAL TESTING > HORMONE REPLACEMENT THERAPY

page 54

 

Visit https://bra.in/8v2ZVe

 

Diagnosis and Treatment of Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysfunction in Patients with Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). Journal Of Chronic Fatigue Syndrome

 

Physiologic replacement of cortisol at doses of 5-15 mg/day have been shown to be safe, with little or no associated risk, and have the potential for significant clinical benefit. Cortisol treatment carries significantly less risk and a greater potential for benefit than treatments considered to be the standard of care in the treatment of CFS/FM, including antidepressants, muscle relaxants and narcotics. The current evidence supports the use of physiologic doses of cortisol as an appropriate component ofa multi-system treatment protocol for CFS and FM, and a therapeutic trial of cortisol should be considered in the majority of these patients, especially those with signs or symptoms consistent with adrenal dysfunction, low blood pressure and/or serum levels that are low or in the low normal range

​

From: Clearfield Panhypopituitarism and TBI

http://www.nevadaosteopathic.org/attachments/article/33/Clearfield%20Panhypopituitarism%20and%20TBI.pdf

 

• 80% of TBI Injuries are mild without LOC (loss of consc

• Acute hormone deficiencies occur in 56% of Head Injuries

• 36% continue on to Chronic Hormone Deficiency

• Psychotropic Meds Mask Symptoms

• Psychotropic meds do not address underlying cause

• Plan: Replace Deficient Hormones to Physiologic Levels

 

 

page 55 PTBICF > TREATMENT CENTERS, SPECIALISTS and CLINICS > HORMONAL TESTING > HORMONE REPLACEMENT THERAPY

page 54